Cost-Minimization Analysis of Risk-Stratified Hematuria Evaluation
نویسندگان
چکیده
منابع مشابه
Evaluation of Hematuria
www.turner-white.com B lood in the urine is a common problem that can be a sign of a number of benign and malignant underlying diseases. Hematuria may be macroscopic (visible on gross examination) or microscopic.1,2 The American Urological Association defines microscopic hematuria as 3 or more red blood cells (RBCs) per high-power field (hpf) on microscopic analysis of 2 or 3 properly collected...
متن کاملThe death of cost-minimization analysis?
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by showing the rare circumstances under which CMA is an appropriate method of analysis. We argue that it is inappropriate for separate and sequen...
متن کاملA particle swarm optimization algorithm for minimization analysis of cost-sensitive attack graphs
To prevent an exploit, the security analyst must implement a suitable countermeasure. In this paper, we consider cost-sensitive attack graphs (CAGs) for network vulnerability analysis. In these attack graphs, a weight is assigned to each countermeasure to represent the cost of its implementation. There may be multiple countermeasures with different weights for preventing a single exploit. Also,...
متن کاملEvaluation of hematuria in children.
The detection of blood in a child's urine is alarming and often prompts many laboratory studies. Hematuria is one of the most important signs of renal or bladder disease, but proteinuria often is a more important diagnostic and prognostic finding. The physician should ensure that serious conditions are not overlooked, avoid unnecessary laboratory studies, reassure the family, and provide guidel...
متن کاملStratified Cost-Effectiveness Analysis To Guide Genetic Screening For Cancer Risk.
In each study, we used a simulation model to identify a subpopulation based on age and clinical risk, for whom we used genetic testing to find intensified prevention measures, which was optimally costeffective. As more genetic tests become available, this method can be used to identify screening strategies that maximize cost-effectiveness. We develop a framework for stratified costeffecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Patient-Centered Research and Reviews
سال: 2016
ISSN: 2330-0698
DOI: 10.17294/2330-0698.1363